drugset / Trial / NCT02518048

A Psoriasis Plaque Test Trial With LEO 90100 Compared to Betesil® in Patients With Psoriasis Vulgaris

NCT02518048

Phase 2 Completed 35 enrolled LEO Pharma
RandomizedSingle-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the anti-psoriatic effect of LEO 90100 aerosol foam compared with Betesil® medicated plaster

Timeline

Start
2015-08
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Calcipotriol Small molecule 50 unknown Topical
Comparator betamethasone dipropionate Small molecule 0.5 unknown Topical
Comparator betamethasone valerate Small molecule 2.25 mg Topical